The large Phase 3 trials of the Pfizer, Moderna and AstraZeneca vaccines were not designed to test whether the vaccines stopped person-to-person transmission of the virus...
The FDA requires that vaccine manufacturers not apply for an Emergency Use Authorisation (EUA) until at least half of the vaccine recipients in the Phase 3 trial have had at least two-months follow up...
English
Japanese
